These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19103363)

  • 1. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Kalb RE; Bagel J; Korman NJ; Lebwohl MG; Young M; Horn EJ; Van Voorhees AS;
    J Am Acad Dermatol; 2009 Jan; 60(1):120-4. PubMed ID: 19103363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation.
    Chan CS; Van Voorhees AS; Lebwohl MG; Korman NJ; Young M; Bebo BF; Kalb RE; Hsu S
    J Am Acad Dermatol; 2009 Jun; 60(6):962-71. PubMed ID: 19375191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Inverse/Intertriginous Psoriasis: Updated Guidelines from the Medical Board of the National Psoriasis Foundation.
    Khosravi H; Siegel MP; Van Voorhees AS; Merola JF
    J Drugs Dermatol; 2017 Aug; 16(8):760-766. PubMed ID: 28809991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in topical sequential therapy for psoriasis.
    Koo JY
    Skin Therapy Lett; 2005 Nov; 10(9):1-4. PubMed ID: 16292458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation.
    Menon K; Van Voorhees AS; Bebo BF; Gladman DD; Hsu S; Kalb RE; Lebwohl MG; Strober BE;
    J Am Acad Dermatol; 2010 Feb; 62(2):291-9. PubMed ID: 19646777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
    Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
    J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
    Lebwohl MG; Tan MH; Meador SL; Singer G
    J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol cream: a review of its use in the management of psoriasis.
    Segaert S; Duvold LB
    J Dermatolog Treat; 2006; 17(6):327-37. PubMed ID: 17853305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing use of more potent treatments for psoriasis.
    Strowd LC; Yentzer BA; Fleischer AB; Feldman SR
    J Am Acad Dermatol; 2009 Mar; 60(3):478-81. PubMed ID: 19058875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriasis in infancy: therapy with calcipotriene ointment.
    Travis LB; Silverberg NB
    Cutis; 2001 Nov; 68(5):341-4. PubMed ID: 11766119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
    Rosmarin DM; Lebwohl M; Elewski BE; Gottlieb AB;
    J Am Acad Dermatol; 2010 May; 62(5):838-53. PubMed ID: 19932926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcipotriol cream in the treatment of flexural psoriasis.
    Duweb GA; Eldebani S; Alhaddar J
    Int J Tissue React; 2003; 25(4):127-30. PubMed ID: 15244317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.